
Olezarsen cut triglycerides 64% but did not change plaque in ESSENCE-TIMI 73b imaging
The ESSENCE-TIMI 73b imaging study found olezarsen lowered triglycerides about 64% and remnant cholesterol about 72%, with ApoB down only about 16%, yet 12-month CCTA showed no difference in plaque. Louis reads it as showing TG lowering alone, without treating insulin resistance, does not slow plaque.
